Literature DB >> 4016081

Circular dichroic evidence for an ordered sequence of ligand/binding site interactions in the catalytic reaction of the cAMP-dependent protein kinase.

J Reed, V Kinzel, B E Kemp, H C Cheng, D A Walsh.   

Abstract

A limiting requirement for substrate specificity of the cAMP-dependent protein kinase is the presence of one or two basic residues located to the N-terminal side of the target substrate serine. Furthermore, circular dichroic (CD) studies have shown that binding of protein substrate involves a series of at least two independent conformational changes in the enzyme, each of which is initiated by a recognition signal on the substrate protein. The present study attempts to elucidate further the complete sequence of enzyme/ligand interactions by using the synthetic substrate peptide Kemptide and analogues differing from it at crucial points in the sequence: the Ala-peptide, where alanine is substituted for the target serine, and D-Ser-Kemptide, where the target serine is in the D rather than the L configuration. Examination of the effects of binding of these substrates on the intrinsic UV CD of the enzyme and the induced CD in the presence of Blue Dextran has revealed a third step in the substrate/enzyme binding interaction. Although sections of the conformational change at the active site are dependent on the basic subsite and the serine hydroxyl group on the peptide, respectively, the complete conformational change requires that the substrate be bound in random coil conformation. Where this does not occur, the kinetics show that the peptide will not act either as substrate or as inhibitor of the enzyme. Further, the interaction between the serine hydroxyl group and an enzyme tyrosine residue, previously observed, appears to be dependent on the correct orientation as well as the mere presence of the target -OH group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016081     DOI: 10.1021/bi00333a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Conserved water molecules contribute to the extensive network of interactions at the active site of protein kinase A.

Authors:  S Shaltiel; S Cox; S S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

2.  An active twenty-amino-acid-residue peptide derived from the inhibitor protein of the cyclic AMP-dependent protein kinase.

Authors:  H C Cheng; S M van Patten; A J Smith; D A Walsh
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

3.  Role of protein kinase A and the serine-rich region of herpes simplex virus type 1 ICP4 in viral replication.

Authors:  K Xia; D M Knipe; N A DeLuca
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

4.  Divalent metal ions influence catalysis and active-site accessibility in the cAMP-dependent protein kinase.

Authors:  J A Adams; S S Taylor
Journal:  Protein Sci       Date:  1993-12       Impact factor: 6.725

5.  An investigation of the role of Glu-842, Glu-844 and His-846 in the function of the cytoplasmic domain of the epidermal growth factor receptor.

Authors:  J F Timms; M E Noble; M Gregoriou
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

6.  Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations.

Authors:  J Zheng; D R Knighton; N H Xuong; S S Taylor; J M Sowadski; L F Ten Eyck
Journal:  Protein Sci       Date:  1993-10       Impact factor: 6.725

7.  Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase.

Authors:  J D Scott; M B Glaccum; E H Fischer; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  Phosphotransferase and substrate binding mechanism of the cAMP-dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5-24).

Authors:  D Bossemeyer; R A Engh; V Kinzel; H Ponstingl; R Huber
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.